. The close-up shows the diversified residues of the monobody CD loops (presented as sticks) for Mb(Lck_1) (green, middle panel) and for Mb(Lck_3) (orange, lower panel) binding to the +3 specificity pocket of the Lck SH2 domain.
SI Figure 7:
Structures of monobodies targeting different SH2 domains. Seven individual co-crystal structures of monobodies targeting SH2 domains (three structures reported in this study and four from previous studies) as well as the pYEEI peptide/Lck complex are shown. The SH2 domains are depicted in white whereas the monobodies and the pYEEI peptide are shown in different colors. The model in the center is a superimposition of all structures aligned to one SH2 domain. PDB entries used were: 3K2M (HA4-Abl SH2), 3UYO (SH13-Abl SH2), 4JE4 (NSa1-Shp2 N-SH2), 4JEG (CS1-Shp2 C-SH2) and 1LKK (pYEEI peptide-Lck SH2).
SI Figure 8:
Alignment of DNA and protein sequences of the SFK SH2 constructs used in our study. The sequences show the expressed protein/mRNA from the pHBT vector including 6xHis tag, AviTag, TEV cleavage site and SH2 sequence until the Stop codon. The alignment has been created with Geneious™ using a standard color scheme of the software. Each amino acid has a different color background in order to make sequence comparison easier.
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SI Figure 9:
Protein sequence alignment of all SFK SH2 domains used in this study. Vertical bars mark the sequence of the FLVRES motif (with a critical Arg residue for pY binding) and the EF-loop (contacted by the FG-loops of Mb(Lck_1) and Mb(Lck_3); see Fig. 7 ). The conservation of the residues at each position is visualized by a scale from black (high conservation) to white (low conservation). 
